2023 Q3 Form 10-Q Financial Statement

#000149315223028505 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $1.911M $5.587M $4.274M
YoY Change 11.95% 30.72% -11.82%
Cost Of Revenue $2.019M $4.112M $3.213M
YoY Change 3.33% 27.98% -17.19%
Gross Profit -$108.0K $1.475M $1.061M
YoY Change -56.28% 39.02% 9.72%
Gross Profit Margin -5.65% 26.4% 24.82%
Selling, General & Admin $1.266M $1.447M $1.436M
YoY Change -30.06% 0.77% 4.89%
% of Gross Profit 98.1% 135.34%
Research & Development $299.0K $338.0K $350.0K
YoY Change -6.27% -3.43% -24.41%
% of Gross Profit 22.92% 32.99%
Depreciation & Amortization $82.00K $110.0K $129.0K
YoY Change -33.87% -14.73% -17.83%
% of Gross Profit 7.46% 12.16%
Operating Expenses $1.565M $1.785M $1.786M
YoY Change -26.49% -0.06% -2.51%
Operating Profit -$1.673M -$310.0K -$725.0K
YoY Change -29.59% -57.24% -16.18%
Interest Expense $171.0K $126.0K $14.00K
YoY Change 1325.0% 800.0% -6.67%
% of Operating Profit
Other Income/Expense, Net -$171.0K -$126.0K -$14.00K
YoY Change 3320.0% 800.0% 1300.0%
Pretax Income -$1.840M -$436.0K -$739.0K
YoY Change -22.72% -41.0% -14.67%
Income Tax
% Of Pretax Income
Net Earnings -$1.844M -$436.0K -$739.0K
YoY Change -22.55% -41.0% -14.67%
Net Earnings / Revenue -96.49% -7.8% -17.29%
Basic Earnings Per Share -$0.14 $0.03 -$0.06
Diluted Earnings Per Share -$0.14 $0.03 -$57.79K
COMMON SHARES
Basic Shares Outstanding 12.95M shares 12.95M shares 12.79M shares
Diluted Shares Outstanding 12.95M shares 12.95M shares 12.79M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $300.0K $292.0K $2.656M
YoY Change -17.36% -89.01% -68.89%
Cash & Equivalents $296.0K $292.0K $2.656M
Short-Term Investments
Other Short-Term Assets $2.940M $3.050M $6.386M
YoY Change -53.54% -52.24% 97.22%
Inventory $19.16M $17.69M $11.99M
Prepaid Expenses $942.0K $1.050M $4.386M
Receivables $1.582M $3.718M $3.994M
Other Receivables $790.0K $787.0K $787.0K
Total Short-Term Assets $24.76M $25.54M $25.81M
YoY Change 1.82% -1.05% 0.58%
LONG-TERM ASSETS
Property, Plant & Equipment $423.0K $505.0K $770.0K
YoY Change -35.62% -34.42% -68.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $110.0K $93.00K $93.00K
YoY Change 18.28% 0.0% -1.06%
Total Long-Term Assets $3.634M $2.776M $1.443M
YoY Change 213.01% 92.38% -43.32%
TOTAL ASSETS
Total Short-Term Assets $24.76M $25.54M $25.81M
Total Long-Term Assets $3.634M $2.776M $1.443M
Total Assets $28.40M $28.31M $27.25M
YoY Change 11.44% 3.89% -3.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.988M $1.429M $135.0K
YoY Change 367.76% 958.52% -63.71%
Accrued Expenses $2.220M $1.959M $1.802M
YoY Change 36.03% 8.71% -9.63%
Deferred Revenue
YoY Change
Short-Term Debt $5.190M $4.927M $0.00
YoY Change -100.0%
Long-Term Debt Due $320.0K $295.0K $248.0K
YoY Change 29.03% 18.95% 4.64%
Total Short-Term Liabilities $11.45M $10.15M $5.670M
YoY Change 94.86% 78.92% 7.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $8.000K $143.0K
YoY Change -100.0% -94.41% -63.33%
Other Long-Term Liabilities $2.160M $1.527M $47.00K
YoY Change 3148.94% -92.6%
Total Long-Term Liabilities $2.160M $1.535M $190.0K
YoY Change 2566.67% 707.89% -81.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.45M $10.15M $5.670M
Total Long-Term Liabilities $2.160M $1.535M $190.0K
Total Liabilities $13.61M $11.68M $5.860M
YoY Change 128.51% 99.32% -7.15%
SHAREHOLDERS EQUITY
Retained Earnings -$22.50M -$20.66M -$15.39M
YoY Change 26.66% 34.28%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $40.00K
YoY Change
Treasury Stock Shares 17.48K shares
Shareholders Equity $14.79M $16.63M $21.39M
YoY Change
Total Liabilities & Shareholders Equity $28.40M $28.31M $27.25M
YoY Change 11.44% 3.89% -3.39%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.844M -$436.0K -$739.0K
YoY Change -22.55% -41.0% -14.67%
Depreciation, Depletion And Amortization $82.00K $110.0K $129.0K
YoY Change -33.87% -14.73% -17.83%
Cash From Operating Activities -$280.0K -$1.648M -$1.464M
YoY Change -87.39% 12.57% -46.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $194.0K -$7.000K
YoY Change -100.0% -2871.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$194.0K -$7.000K
YoY Change -100.0% 2671.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 280.0K 2.015M -59.00K
YoY Change -551.61% -3515.25% -11.94%
NET CHANGE
Cash From Operating Activities -280.0K -1.648M -1.464M
Cash From Investing Activities 0.000 -194.0K -7.000K
Cash From Financing Activities 280.0K 2.015M -59.00K
Net Change In Cash -0.0000000003492 173.0K -1.530M
YoY Change -100.0% -111.31% -45.71%
FREE CASH FLOW
Cash From Operating Activities -$280.0K -$1.648M -$1.464M
Capital Expenditures $0.00 $194.0K -$7.000K
Free Cash Flow -$280.0K -$1.842M -$1.457M
YoY Change -87.34% 26.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001622345
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
POLA Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
POLA Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
POLA Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37960
dei Entity Registrant Name
EntityRegistrantName
POLAR POWER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0479020
dei Entity Address Address Line1
EntityAddressAddressLine1
249 E. Gardena Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Gardena
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90248
dei City Area Code
CityAreaCode
(310)
dei Local Phone Number
LocalPhoneNumber
830-9153
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
POLA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12949550 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
292000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
211000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3718000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2230000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
17689000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
15460000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2629000 usd
CY2023Q2 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2022Q4 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
787000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
787000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
25536000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23317000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2178000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
240000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
505000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
538000 usd
CY2023Q2 us-gaap Deposit Assets
DepositAssets
93000 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
93000 usd
CY2023Q2 us-gaap Assets
Assets
28312000 usd
CY2022Q4 us-gaap Assets
Assets
24188000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1429000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
230000 usd
CY2023Q2 us-gaap Deposits
Deposits
1535000 usd
CY2022Q4 us-gaap Deposits
Deposits
2126000 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1242000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1231000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
717000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
268000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
135000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
211000 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4927000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1884000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10145000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5950000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
8000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
57000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1527000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
11680000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6007000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12967027 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12949550 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12967027 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12949550 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37331000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37331000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20660000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19111000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17477 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17477 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16632000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18181000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28312000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24188000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5587000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4274000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9777000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7983000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4112000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3213000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7548000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6017000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1475000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1061000 usd
us-gaap Gross Profit
GrossProfit
2229000 usd
us-gaap Gross Profit
GrossProfit
1966000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
310000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
400000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
642000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
805000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
338000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
350000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
684000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
826000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1137000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1036000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2248000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2167000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1785000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1786000 usd
us-gaap Operating Expenses
OperatingExpenses
3574000 usd
us-gaap Operating Expenses
OperatingExpenses
3798000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-310000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-725000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1345000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1832000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
126000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
14000 usd
us-gaap Interest Expense
InterestExpense
204000 usd
us-gaap Interest Expense
InterestExpense
27000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-126000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-204000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-436000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-739000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1549000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1859000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12949550 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12949550 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12788203 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12788203 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12949550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12949550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12788203 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12788203 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
17068000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-436000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16632000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18181000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1549000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16632000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22130000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-739000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21391000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23250000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1859000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21391000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1549000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1859000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
226000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
264000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1488000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-249000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2229000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2968000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1579000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
380000 usd
POLA Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-454000 usd
POLA Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-334000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1199000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-193000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-591000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2588000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-416000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-354000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2804000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2311000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3044000 usd
POLA Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
-160000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
125000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
119000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3079000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-119000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
81000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2445000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
211000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5101000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
292000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2656000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1549000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2804000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
292000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
71000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16632000 usd
CY2023Q2 POLA Working Capital
WorkingCapital
15391000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zNU35D3UvOG4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zK8cNw2aoXJ">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory net realizable value, impairment analysis of long-term assets, valuation allowance on deferred tax assets, accruals for potential liabilities, accruals for warranty reserves, assumptions made in valuing equity instruments issued for services, and assumptions used in the determination of the Company’s liquidity. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5587000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4274000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9777000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7983000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5587000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4274000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9777000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7983000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5587000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4274000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9777000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7983000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
14404000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12277000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3285000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3183000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
17689000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
15460000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
242000 usd
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
508000 usd
POLA Standard Product Warranty Accrual Provision
StandardProductWarrantyAccrualProvision
242000 usd
CY2022 POLA Standard Product Warranty Accrual Provision
StandardProductWarrantyAccrualProvision
508000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
211000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
8000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
57000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
499000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
350000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zjTkbObr3dW8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zrzMnos9P9l5">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash</i>. The Company maintains cash balances at four banks, with the majority held at one bank located in the U.S. At times, the amount on deposit exceeds the federally insured limits. Management believes that the financial institutions that hold the Company’s cash are financially sound and, accordingly, minimal credit risk exists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash denominated in Australian Dollars with a U.S. Dollar equivalent of $<span id="xdx_906_eus-gaap--Cash_iI_pn3n3_c20230630__srt--CurrencyAxis__currency--AUD_z9ZW4dzzRn26" title="Cash">6</span> and $<span id="xdx_90D_eus-gaap--Cash_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--AUD_zouMalhygZ3b" title="Cash">8</span> at June 30, 2023 and December 31, 2022, respectively, was held in an account at a financial institution located in Australia. Cash denominated in Romanian Leu with a U.S. Dollar equivalent of $<span id="xdx_901_eus-gaap--Cash_iI_pn3n3_c20230630__srt--CurrencyAxis__currency--RON_zhQBFqOAQ46i" title="Cash">18</span> and $<span id="xdx_901_eus-gaap--Cash_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--RON_zd5b4UdC6Url" title="Cash">23</span> at June 30, 2023 and December 31, 2022, respectively, was held in an account at a financial institution located in Romania.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues. </i>For the three months ended June 30, 2023, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znmEOXNUIoog" title="Concentration risk">49</span>% of revenues were generated from the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzXGesdwtMjb" title="Concentration risk">26</span>% of revenue was generated from the Company’s second largest customer, a telecommunications customer outside the U.S. For the three months ended June 30, 2022, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zirWGtDj2Gg6" title="Concentration risk">88</span>% of revenues were generated from the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S. There was no other revenue from customers in excess of 10% of revenues in either period. For the three months ended June 30, 2023 and June 30, 2022, sales to telecommunications customers accounted for<span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zr7oWF3X2hej" title="Concentration risk"> 97</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zaGunMTw0wy9" title="Concentration risk">99</span>% of total revenues, respectively. For the three months ended June 30, 2023 and June 30, 2022, sales to international customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zYGifgVreXOh" title="Concentration risk">29</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zCzadS6R4zl6" title="Concentration risk">2</span>%, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six months ended June 30, 2023, sales to the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S., accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgE4L378fs7" title="Concentration risk">49</span>% of total revenues, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjAAwCvsMoT1" title="Concentration risk">26</span>% of revenue was generated from the Company’s second largest customer, a telecommunications customer outside the U.S. For the same period in 2022, sales to the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S., accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ze5kNqzI4uFc" title="Concentration risk">89</span>%. There was no other revenue from customers in excess of 10% of revenues in either period. For the six months ended June 30, 2023 and June 30, 2022, sales to telecommunications customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zcuuVEsYPork" title="Concentration risk">96</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z2vzlALMreo2" title="Concentration risk">99</span>% of total revenues, respectively. For the six months ended June 30, 2023 and June 30, 2022, sales to international customers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zlg86ex24W25" title="Concentration risk">28</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zQyOobIdwSFg" title="Concentration risk">1</span>%, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At June 30, 2023, the three largest accounts receivable from the Company’s customers represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMQCjsjE2XWh" title="Concentration risk">73</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7Dztah9tdA5" title="Concentration risk">12</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zKMlVzEiJdD7" title="Concentration risk">10</span>%, of the Company’s total accounts receivable. At December 31, 2022, the Company’s two largest receivable accounts represented <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJ0EDDm1Yu0j" title="Concentration risk">74</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0XT1NZs0BI9" title="Concentration risk">15</span>% of the Company’s total accounts receivable. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of June 30, 2023 or December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. At June 30, 2023, accounts payable to the Company’s three largest vendors represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestVendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zFfYI98fStVj" title="Concentration risk">19</span>%, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestVendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zop2iyLdPCm2" title="Concentration risk">11</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__srt--MajorCustomersAxis__custom--LargestVendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z5SQebPGJWo5" title="Concentration risk">5</span>%, of the Company’s accounts payable. On December 31, 2022, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zf6uAjPlto1f" title="Concentration risk">51</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zHKdyFy0w3sf" title="Concentration risk">3</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zmLYphlvKnth" title="Concentration risk">3</span>%, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164122 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164122 shares
CY2023Q1 POLA Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities
InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities
2392000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1304000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
31000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
37000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
41000 usd
CY2023Q2 POLA Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities
InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities
1184000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4494000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4300000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3989000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3762000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
505000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
538000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
110000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
129000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
125000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
125000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
226000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
264000 usd
us-gaap Depreciation
Depreciation
220000 usd
us-gaap Depreciation
Depreciation
255000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
143000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
268000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
135000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
140000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.22
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
24122 shares
CY2022Q4 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
24122 shares
CY2023Q2 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2023Q2 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2023Q2 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
3.13
CY2023Q2 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2022Q4 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.13
POLA Description Of Warrant Expiration Date
DescriptionOfWarrantExpirationDate
expire in July 2025
CY2023Q2 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2596000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
58000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
74000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
84000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
499000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
350000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0613 pure
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0375 pure
CY2023Q2 POLA Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
2510000 usd
CY2022Q4 POLA Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
2237000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2178000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
580000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
717000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
588000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1527000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2244000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
635000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
400000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
858000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
990000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
168000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2416000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
172000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2244000 usd
us-gaap Payments For Rent
PaymentsForRent
649000 usd
us-gaap Payments For Rent
PaymentsForRent
476000 usd
CY2021 POLA Employee Retention Credits Wages Percentage
EmployeeRetentionCreditsWagesPercentage
0.70 pure
CY2021 POLA Employee Retention Credits Per Shares
EmployeeRetentionCreditsPerShares
7
CY2021Q4 POLA Expenses Of Employee Retention Credit
ExpensesOfEmployeeRetentionCredit
2000000 usd
CY2022Q4 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2023Q2 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd

Files In Submission

Name View Source Status
0001493152-23-028505-index-headers.html Edgar Link pending
0001493152-23-028505-index.html Edgar Link pending
0001493152-23-028505.txt Edgar Link pending
0001493152-23-028505-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
pola-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pola-20230630_cal.xml Edgar Link unprocessable
pola-20230630_def.xml Edgar Link unprocessable
pola-20230630_lab.xml Edgar Link unprocessable
pola-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending